Masimo Renews $1Million Pulse Oximeter Bet To “Separate Fact From Fiction”

Masimo, the inventor of measure-through motion and low perfusion pulse oximetry today renewed its $1,000,000 guarantee that Masimo SET® Pulse Oximetry and rainbow® Pulse CO-Oximetry™ will outperform all Nellcor™ pulse oximeters, including the three that Covidien recently announced have received FDA 510(k) clearance with motion claims.

Masimo Renews $1,000,000 Guarantee that Masimo SET® Will Outperform All Covidien Nellcor™ Pulse Oximeters (via PR Newswire)

The Renewal Addresses Recent Covidien Announcements and Potential Confusion Over Pulse Oximetry Performance Crucial to Patient Care IRVINE, Calif., May 30, 2013 /PRNewswire/ — Masimo (NASDAQ: MASI), the inventor of measure-through motion and low perfusion pulse oximetry today renewed its $1,000,000…

published: June 3, 2013 in: Anaesthesia, Covidien, Monitoring

Most read

Latest

^